Literature DB >> 35787553

Crystal structure of the catalytic domain of human RPTPH.

Myeongbin Kim1, Seong Eon Ryu1.   

Abstract

Receptor-type protein tyrosine phosphatases (RPTPs) receive extracellular stimuli and transfer them into cells. They regulate cell growth, differentiation and death via specific signals. They have also been implicated in cancer, diabetes and neurological diseases. RPTPH, a member of the type 3 RPTP (R3-PTP) family, is an important regulator of colorectal cancer and hepatic carcinoma. Despite its importance in drug development, the structure of RPTPH has not yet been resolved. Here, the crystal structure of the catalytic domain of RPTPH was determined at 1.56 Å resolution. Despite similarities to other R3-PTPs in its overall structure, RPTPH exhibited differences in its loop regions and side-chain conformations. Compared with other R3-PTPs, RPTPH has unique side chains near its active site that may confer specificity for inhibitor binding. Therefore, detailed information on the structure of RPTPH provides clues for the development of specific inhibitors.

Entities:  

Keywords:  colorectal cancer; crystal structure; hepatic carcinoma; human RPTPH; loop conformation; specific inhibitor development

Mesh:

Substances:

Year:  2022        PMID: 35787553      PMCID: PMC9254897          DOI: 10.1107/S2053230X22006173

Source DB:  PubMed          Journal:  Acta Crystallogr F Struct Biol Commun        ISSN: 2053-230X            Impact factor:   1.072


  21 in total

1.  Multiparametric scaling of diffraction intensities.

Authors:  Zbyszek Otwinowski; Dominika Borek; Wladyslaw Majewski; Wladek Minor
Journal:  Acta Crystallogr A       Date:  2003-04-25       Impact factor: 2.290

2.  Engineering the catalytic domain of human protein tyrosine phosphatase beta for structure-based drug discovery.

Authors:  Artem G Evdokimov; Matthew Pokross; Richard Walter; Marlene Mekel; Brooke Cox; Chuiying Li; Randy Bechard; Frank Genbauffe; Ryan Andrews; Conrad Diven; Brian Howard; Vinit Rastogi; Jeffrey Gray; Matthew Maier; Kevin G Peters
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-11-23

Review 3.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

Review 4.  Receptor-type tyrosine phosphatase ligands: looking for the needle in the haystack.

Authors:  Alma N Mohebiany; Roman M Nikolaienko; Samuel Bouyain; Sheila Harroch
Journal:  FEBS J       Date:  2012-07-05       Impact factor: 5.542

5.  Overexpression of SAP-1, a transmembrane-type protein tyrosine phosphatase, in human colorectal cancers.

Authors:  Y Seo; T Matozaki; M Tsuda; Y Hayashi; H Itoh; M Kasuga
Journal:  Biochem Biophys Res Commun       Date:  1997-02-24       Impact factor: 3.575

6.  Improvement of molecular-replacement models with Sculptor.

Authors:  Gábor Bunkóczi; Randy J Read
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

7.  Prognostic implication of PTPRH hypomethylation in non-small cell lung cancer.

Authors:  Takashi Sato; Kenzo Soejima; Eri Arai; Junko Hamamoto; Hiroyuki Yasuda; Daisuke Arai; Kota Ishioka; Keiko Ohgino; Katsuhiko Naoki; Takashi Kohno; Koji Tsuta; Shun-Ichi Watanabe; Yae Kanai; Tomoko Betsuyaku
Journal:  Oncol Rep       Date:  2015-06-25       Impact factor: 3.906

8.  PTPσ inhibitors promote hematopoietic stem cell regeneration.

Authors:  Yurun Zhang; Martina Roos; Heather Himburg; Christina M Termini; Mamle Quarmyne; Michelle Li; Liman Zhao; Jenny Kan; Tiancheng Fang; Xiao Yan; Katherine Pohl; Emelyne Diers; Hyo Jin Gim; Robert Damoiseaux; Julian Whitelegge; William McBride; Michael E Jung; John P Chute
Journal:  Nat Commun       Date:  2019-08-14       Impact factor: 14.919

9.  Large-scale structural analysis of the classical human protein tyrosine phosphatome.

Authors:  Alastair J Barr; Emilie Ugochukwu; Wen Hwa Lee; Oliver N F King; Panagis Filippakopoulos; Ivan Alfano; Pavel Savitsky; Nicola A Burgess-Brown; Susanne Müller; Stefan Knapp
Journal:  Cell       Date:  2009-01-23       Impact factor: 41.582

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.